Search research articles
Contact Us
Filters
Showing results (31-40 of 243) with videos related to
Page
of 25
Sort By:
Advances in Biological Regulation
|
July 24, 2021
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Emanuela Ricciotti, Krzysztof Laudanski, Garret A FitzGerald
The Journal of Clinical Investigation
|
January 6, 2006
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
Tilo Grosser, Susanne Fries, Garret A FitzGerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Annual Review of Medicine
|
January 12, 2010
Emotion recollected in tranquility: lessons learned from the COX-2 saga
Tilo Grosser, Ying Yu, Garret A Fitzgerald
Nature Communications
|
November 3, 2022
Tempo: an unsupervised Bayesian algorithm for circadian phase inference in single-cell transcriptomics
Benjamin J Auerbach, Garret A FitzGerald, Mingyao Li
Cancer Research
|
April 24, 2021
Aspirin in Hepatocellular Carcinoma
Emanuela Ricciotti, Kirk J Wangensteen, Garret A FitzGerald
Science Translational Medicine
|
February 24, 2012
Recalibrating intellectual property rights to enhance translational research collaborations
Tania Bubela, Garret A FitzGerald, E Richard Gold
Cell
|
November 24, 2014
Time in motion: the molecular clock meets the microbiome
Xue Liang, Frederic D Bushman, Garret A FitzGerald
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2022
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
J David Spence, Tilo Grosser, Garret A FitzGerald
Methods in Enzymology
|
February 25, 2015
Clocks and cardiovascular function
Sarah C McLoughlin, Philip Haines, Garret A FitzGerald
Page
of 25
Search research articles
Search
Showing results (31-40 of 243) with videos related to
Sort By:
Page
of 25
Advances in Biological Regulation
|
July 24, 2021
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Emanuela Ricciotti, Krzysztof Laudanski, Garret A FitzGerald
The Journal of Clinical Investigation
|
January 6, 2006
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
Tilo Grosser, Susanne Fries, Garret A FitzGerald
Trends in Pharmacological Sciences
|
June 28, 2017
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser, Emanuela Ricciotti, Garret A FitzGerald
Annual Review of Medicine
|
January 12, 2010
Emotion recollected in tranquility: lessons learned from the COX-2 saga
Tilo Grosser, Ying Yu, Garret A Fitzgerald
Nature Communications
|
November 3, 2022
Tempo: an unsupervised Bayesian algorithm for circadian phase inference in single-cell transcriptomics
Benjamin J Auerbach, Garret A FitzGerald, Mingyao Li
Cancer Research
|
April 24, 2021
Aspirin in Hepatocellular Carcinoma
Emanuela Ricciotti, Kirk J Wangensteen, Garret A FitzGerald
Science Translational Medicine
|
February 24, 2012
Recalibrating intellectual property rights to enhance translational research collaborations
Tania Bubela, Garret A FitzGerald, E Richard Gold
Cell
|
November 24, 2014
Time in motion: the molecular clock meets the microbiome
Xue Liang, Frederic D Bushman, Garret A FitzGerald
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2022
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
J David Spence, Tilo Grosser, Garret A FitzGerald
Methods in Enzymology
|
February 25, 2015
Clocks and cardiovascular function
Sarah C McLoughlin, Philip Haines, Garret A FitzGerald
Page
of 25